Related Experiment Video
Updated: Aug 10, 2026

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
Published on: August 31, 2013
Arthritis following recombinant outer surface protein A vaccination for Lyme disease
C D Rosé1, P T Fawcett, K M Gibney
1Department of Pediatrics, duPont Hospital for Children, Wilmington, Delaware 19899, USA.
Abstract:
As more individuals receive outer surface protein A (OspA) vaccination, adverse effects not detected during phase III clinical trials may become apparent. Although arthritis has been described following other human vaccines, we found no reports of human cases after Lyme disease vaccination. We describe 4 males (2 children, 2 adults) who developed arthritis following recombinant OspA vaccination. The potential arthritogenic effect of OspA suggested by in vitro and animal studies finds a clinical correlate in these 4 cases.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
08:32A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
Published on: March 20, 2026
Related Concept Videos
Cross-reactivity
Vaccinations
Bacterial Meningitis
Streptococcal Pharyngitis
Bacterial Meningitis II: Pathophysiology
Hypersensitivity Reactions: Immune-Complex Reactions